---
layout: post
title: "高端在疫苗紧急使用授权申请通过后股价涨停"
date: 2021-07-20T04:48:20.005Z
author: 联合早报
from: https://www.zaobao.com/realtime/china/story20210720-1171301
tags: [ 联合早报 ]
categories: [ 联合早报 ]
---
<!--1626781380000-->
[高端在疫苗紧急使用授权申请通过后股价涨停](https://www.zaobao.com/realtime/china/story20210720-1171301)
------

<div>
<p>台湾疫苗制造商高端在冠病疫苗紧急使用授权（EUA）申请通过后，股价今天（20日）涨停。高端股价涨停也带动台湾疫苗相关股大涨。</p><p>综合台湾《经济日报》和中时新闻网报道，在台湾上市的高端疫苗股价今天狂升10%后涨停锁死。</p><p>在疫苗相关股方面，基亚、云辰和台康生技的股价截至今早11时半都比起前一个交易日的闭市价大涨近10%。</p><section id="imu"><div id="dfp-ad-imu1">        </div></section><p>台湾卫生福利部昨天宣布，由于高端冠病疫苗达到相关标准，通过EUA核准这款本土研发的疫苗进行专案制造。</p><p>台湾总统府曾在3月宣示，一旦台产疫苗研发成功，总统蔡英文及副总统赖清德愿意以实际行动支持台产疫苗。总统府发言人张惇涵昨天说，将依照指挥中心开放施打计划，妥适进行后续相关规划；若有定案将适时对外说明。</p><p>面对媒体提问蔡英文总统是否会带头施打台产疫苗，中央流行疫情指挥中心指挥官、卫福部长陈时中回应称，还是尊重蔡英文本人的意愿。<br> </p>      <div id="innity-in-post"></div><div id="dfp-ad-midarticlespecial">        </div>      <a href="https://subscribe.sph.com.sg/promotions/chinese-3-months-99-cents-promotion/?utm_campaign=cn3in199c&utm_medium=sph-publication&utm_source=zb&utm_content=subscribelink-free-endofarticle" target="_blank"><img class="view-desktop lazyload  " data-src="https://static.zaobao.com/s3fs-public/freemium_images/20210209/399-default-desktop-l_0_1.jpg" alt style="width:100%;" pinger-seen="true" src="https://static.zaobao.com/s3fs-public/freemium_images/20210209/399-default-desktop-l_0_1.jpg" referrerpolicy="no-referrer"></a>      <a href="https://subscribe.sph.com.sg/promotions/chinese-3-months-99-cents-promotion/?utm_campaign=cn3in199c&utm_medium=sph-publication&utm_source=zb&utm_content=subscribelink-free-endofarticle" target="_blank"><img class="view-mobile lazyload " data-src="https://static.zaobao.com/s3fs-public/freemium_images/20210209/399-default-mobile_1.jpg" alt pinger-seen="true" src="https://static.zaobao.com/s3fs-public/freemium_images/20210209/399-default-mobile_1.jpg" referrerpolicy="no-referrer"></a>
</div>
